UZH-Logo

Maintenance Infos

Browse by Communities & Collections - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items at this level: 1665.

Abascal, Federico

Abascal, Federico; Corpet, Armelle; Gurard-Levin, Zachary A; Juan, David; Ochsenbein, Françoise; Rico, Daniel; Valencia, Alfonso; Almouzni, Geneviève (2013). Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution, 30(8):1853-1866.

Abitabile, P

Maurer, M M; Badir, S; Pensalfini, M; Bajka, M; Abitabile, P; Zimmermann, R; Mazza, E (2015). Challenging the in-vivo assessment of biomechanical properties of the uterine cervix: A critical analysis of ultrasound based quasi-static procedures. Journal of Biomechanics, 48(9):1541-1548.

Abou Hadeed, May Khaled Ibrahim

Abou Hadeed, May Khaled Ibrahim. Evaluation Schweizer Guidelines für die Indikation der Hysterektomie im Zusammenhang mit dem Outcome für Patientinnen. 2010, University of Zurich, Faculty of Medicine.

Achtari, C

Achtari, C; Fink, D; Günthert, A R; Huober, J; Pestalozzi, B; Petignat, P; von Moos, R; Sessa, C (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer – some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 35(1):35-38.

Ackerknecht-Koch, Annemarie

Ackerknecht-Koch, Annemarie. Expression von Steroidhormon-Rezeptoren bei Frauen mit Zystozele. 2012, University of Zurich, Faculty of Medicine.

Aebi, Stefan

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Aeschlimann, A

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Agca, Cavit

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Ahmad, A S

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Alexander, H

Horn, L-C; Hentschel, B; Meinel, A; Alexander, H; Leo, C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Annals of Diagnostic Pathology, 13(6):373-377.

Almouzni, Geneviève

Abascal, Federico; Corpet, Armelle; Gurard-Levin, Zachary A; Juan, David; Ochsenbein, Françoise; Rico, Daniel; Valencia, Alfonso; Almouzni, Geneviève (2013). Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution, 30(8):1853-1866.

Altermatt, H J

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Altmeyer, Matthias

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Angst, F

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Ashton-Miller, J A

Betschart, C; Chen, L; Ashton-Miller, J A; Delancey, J O L (2013). On pelvic reference lines and the MR evaluation of genital prolapse: a proposal for standardization using the Pelvic Inclination Correction System. International urogynecology journal and pelvic floor dysfunction, 24(9):1421-1428.

Ashton-Miller, James A

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Author's reply to letter from Matthes and Zucca-Matthes on "Quantitative analyses of variability in normal vaginal shape and dimension on MR images". International Urogynecology Journal and Pelvic Floor Dysfunction, 27(10):1611.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Quantitative analyses of variability in normal vaginal shape and dimension on MR images. International Urogynecology Journal and Pelvic Floor Dysfunction, 27(7):1087-1095.

Kim, Jinyong; Betschart, Cornelia; Ramanah, Rajeev; Ashton-Miller, James A; DeLancey, John O L (2015). Anatomy of the pubovisceral muscle origin: Macroscopic and microscopic findings within the injury zone. Neurourology and Urodynamics, 34(8):774-780.

Betschart, Cornelia; Kim, Jinyong; Miller, Janis M; Ashton-Miller, James A; DeLancey, John O L (2014). Comparison of muscle fiber directions between different levator ani muscle subdivisions: in vivo MRI measurements in women. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(9):1263-1268.

Luo, Jiajia; Betschart, Cornelia; Chen, Luyun; Ashton-Miller, James A; Delancey, John O L (2014). Using stress MRI to analyze the 3D changes in apical ligament geometry from rest to maximal Valsalva: a pilot study. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(2):197-203.

Ashworth, A

Dedes, K J; Wetterskog, D; Ashworth, A; Kaye, S B; Reis-Filho, J S (2011). Emerging therapeutic targets in endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):261-271.

Wilkerson, P M; Dedes, K J; Wetterskog, D; Mackay, A; Lambros, M B; Mansour, M; Frankum, J; Lord, C J; Natrajan, R; Ashworth, A; Reis-Filho, J S (2011). Functional characterization of EMSY gene amplification in human cancers. Journal of Pathology, 225(1):29-42.

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Dedes, K J; Wilkerson, P M; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, J S (2011). Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle, 10(8):1192-1199.

Forster, M D; Dedes, K J; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C J; Weigelt, B; Kaye, S B; Rhoda Molife, L (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):302-306.

Lambros, M B; Natrajan, R; Geyer, F C; Lopez-Garcia, M A; Dedes, K J; Savage, K; Lacroix-Triki, M; Jones, R L; Lord, C J; Linardopoulos, S; Ashworth, A; Reis-Filho, J S (2010). PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Modern Pathology, 23(10):1334-1345.

Dedes, K J; Wetterskog, D; Mendes-Pereira, A M; Natrajan, R; Lambros, M B; Geyer, F C; Vatcheva, R; Savage, K; Mackay, A; Lord, C J; Ashworth, A; Reis-Filho, J S (2010). PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Science Translational Medicine, 2(53):53ra75.

Badir, S

Badir, S; Mazza, E; Bajka, M (2016). Objective assessment of cervical stiffness after administration of misoprostol for intrauterine contraceptive insertion. Ultrasound international open, 2(2):E63-E67.

Maurer, M M; Badir, S; Pensalfini, M; Bajka, M; Abitabile, P; Zimmermann, R; Mazza, E (2015). Challenging the in-vivo assessment of biomechanical properties of the uterine cervix: A critical analysis of ultrasound based quasi-static procedures. Journal of Biomechanics, 48(9):1541-1548.

Bajka, M; Badir, S (2015). Fundus thickness assessment by 3D transvaginal ultrasound allows metrics-based diagnosis and treatment of congenital uterine anomalies. Ultraschall in der Medizin, 38(02):183-189.

Hollenstein, M; Bajka, M; Röhrnbauer, B; Badir, S; Mazza, E (2012). Measuring the in vivo behavior of soft tissue and organs using the aspiration device. In: Payan, Y. Soft Tissue Biomechanical Modeling for Computer Assisted Surgery. Heidelberg: Springer, 201-228.

Badir, Sabrina

Badir, Sabrina; Bajka, Michael; Mazza, Edoardo (2013). A novel procedure for the mechanical characterization of the uterine cervix during pregnancy. Journal of the Mechanical Behavior of Biomedical Materials, 27:143-153.

Baege, A

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Baege, A C

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Baege, Astrid

Baege, Astrid; Ghisu, Gian-Piero; Betschart, Cornelia; Fink, Daniel (2016). Die HPV-Impfung und -Typisierung in der Primär- und Sekundärprävention: Stellenwert in der Praxis. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):20-24.

Betschart, Cornelia; Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2016). Normale und abnormale kolposkopische Befunde: Klassifikation und Bedeutung: Welche Befunde sind „gefährlich“? Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):6-13.

Ghisu, Gian-Piero; Baege, Astrid; Betschart, Cornelia; Fink, Daniel (2016). Therapie bei dysplastischen Veränderungen in der Gynäkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 4:14-19.

Baege, Astrid; Ghisu, Gian-Piero; Fink, Daniel (2014). Follow-up nach Therapie einer CIN, einer VIN und einer VAIN. Gynäkologie, 4:20-24.

Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2014). HPV-assoziierte Genitalerkrankungen. Gynäkologie, 4:14-19.

Baessler, Kaven

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Bajka, M

Badir, S; Mazza, E; Bajka, M (2016). Objective assessment of cervical stiffness after administration of misoprostol for intrauterine contraceptive insertion. Ultrasound international open, 2(2):E63-E67.

Maurer, M M; Badir, S; Pensalfini, M; Bajka, M; Abitabile, P; Zimmermann, R; Mazza, E (2015). Challenging the in-vivo assessment of biomechanical properties of the uterine cervix: A critical analysis of ultrasound based quasi-static procedures. Journal of Biomechanics, 48(9):1541-1548.

Bajka, M; Badir, S (2015). Fundus thickness assessment by 3D transvaginal ultrasound allows metrics-based diagnosis and treatment of congenital uterine anomalies. Ultraschall in der Medizin, 38(02):183-189.

Hollenstein, M; Bajka, M; Röhrnbauer, B; Badir, S; Mazza, E (2012). Measuring the in vivo behavior of soft tissue and organs using the aspiration device. In: Payan, Y. Soft Tissue Biomechanical Modeling for Computer Assisted Surgery. Heidelberg: Springer, 201-228.

Hirsch, S; Szczerba, D; Lloyd, B; Bajka, M; Kuster, N; Székely, G (2011). Mechano-chemical simulation of solid tumor dynamics for therapy outcome predictions. International Journal for Multiscale Computational Engineering, 9(2):231-241.

Bajka, M (2011). Zystischer Unterbauchtumor. Praxis, 100(25):1543-1548.

Bajka, M; Tuchschmid, S; Fink, D; Székely, G; Harders, M (2010). Establishing construct validity of a virtual-reality training simulator for hysteroscopy via a multimetric scoring system. Surgical Endoscopy, 24(1):79-88.

Bajka, M; Tuchschmid, S; Streich, M; Fink, D; Székely, G; Harders, M (2009). Evaluation of a new virtual-reality training simulator for hysteroscopy. Surgical Endoscopy, 23(9):2026-2033.

Bajka, M; Weiss, S; Kunz, J; Fischer, H; Székely, G; Niederer, P (2009). Pressure-dependent hydrometra dimensions in hysteroscopy. Surgical Endoscopy, 23(9):2102-2109.

Bauer, M; Mazza, E; Jabareen, M; Sultan, L; Bajka, M; Lang, U; Zimmermann, R; Holzapfel, G A (2009). Assessment of the in vivo biomechanical properties of the human uterine cervix in pregnancy using the aspiration test: a feasibility study. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144(Suppl ):S77-S81.

Niederer, P; Weiss, S; Caduff, R; Bajka, M; Szekély, G; Harders, M (2009). Uterus models for use in virtual reality hysteroscopy simulators. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144, S:S90-S95.

Mazza, E; Grau, P; Hollenstein, M; Bajka, M (2008). Constitutive modeling of human liver based on in vivo measurements. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Berlin / Heidelberg: Springer, 726-733.

Weiss, S; Niederer, P; Navarini, A; Caduff, R; Bajka, M (2008). Inverse finite element characterization of the human myometrium derived from uniaxial compression experiments. Biomedizinische Technik. Biomedical Engineering, 53(2):52-58.

Tuchschmid, S; Bajka, M; Szczerba, D; Lloyd, B A; Székely, G; Harders, M (2008). Modeling intravasation of liquid distension media in surgical simulators. Medical Image Analysis, 12(5):567-576.

Bajka, Michael

Myers, Kristin M; Feltovich, Helen; Mazza, Edoardo; Vink, Joy; Bajka, Michael; Wapner, Ronald J; Hall, Timothy J; House, Michael (2015). The mechanical role of the cervix in pregnancy. Journal of Biomechanics, 48(9):1511-1523.

Mazza, Edoardo; Parra-Saavedra, Miguel; Bajka, Michael; Gratacos, Eduard; Nicolaides, Kypros; Deprest, Jan (2014). In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy. Prenatal Diagnosis, 34(1):33-41.

Badir, Sabrina; Bajka, Michael; Mazza, Edoardo (2013). A novel procedure for the mechanical characterization of the uterine cervix during pregnancy. Journal of the Mechanical Behavior of Biomedical Materials, 27:143-153.

Bajka, Michael (2013). Antikonzeption – Wo der Ultraschall massgeblich unterstützt. Praxis, 102(12):713-719.

Panel, Pierre; Bajka, Michael; Le Tohic, Arnaud; Ghoneimi, Alaa El; Chis, Carmen; Cotin, Stéphane (2012). Hysteroscopic placement of tubal sterilization implants: virtual reality simulator training. Surgical Endoscopy, 26(7):1986-1996.

Bajrami, I

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Barchiesi, F

Barchiesi, F; Lucchinetti, E; Zaugg, M; Ogunshola, O O; Wright, M; Meyer, Markus; Rosselli, M; Schaufelberger, S; Gillespie, D G; Jackson, E K; Dubey, R K (2010). Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension, 56(5):964-972.

Barghorn, A

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Barth, J

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Barton, C A

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Basler, Michelle

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Bauer, M

Bauer, M; Mazza, E; Jabareen, M; Sultan, L; Bajka, M; Lang, U; Zimmermann, R; Holzapfel, G A (2009). Assessment of the in vivo biomechanical properties of the human uterine cervix in pregnancy using the aspiration test: a feasibility study. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144(Suppl ):S77-S81.

Baumann, Marc

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Baños, A

Matzinger, B; Wolf, M; Baños, A; Fink, D; Hornung, R (2009). Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers in Medical Science, 24(4):561-566.

Stahel, M C; Wolf, M; Baños, A; Hornung, R (2009). Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles. Lasers in Medical Science, 24(6):901-907.

Baños, A. Frequency Domain Near-Infrared Spectroscopy of The Uterine Cervix During Cervical Ripening. 2008, University of Zurich, Faculty of Medicine.

Beale, P

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Behnke, S

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Bellini, Elisa

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Beneder, C

Dedes, K J; Beneder, C; Samartzis, N; Muller, M D; Fink, D; Fehr, M K (2008). Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. Journal of Reproductive Medicine, 53(12):947-951.

Berclaz, G

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Betschart, C

Betschart, C; Chen, L; Ashton-Miller, J A; Delancey, J O L (2013). On pelvic reference lines and the MR evaluation of genital prolapse: a proposal for standardization using the Pelvic Inclination Correction System. International urogynecology journal and pelvic floor dysfunction, 24(9):1421-1428.

Betschart, C; Perucchini, D; Scheiner, D (2012). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Ars Medici, (III):23-26.

Scheiner, D; Perucchini, D; Fink, Daniel; Betschart, C (2012). Gynäkologie: Fälle aus der Harninkontinenz-Sprechstunde. Praxis, 101(9):585-592.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 1: Abklärung bei Harninkontinenz und Genitaldeszensus. Gynäkologie, (2):34-38.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 2: Die Behandlung bei Genitaldeszensus. Gynäkologie, (3):34-38.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 3: Die Behandlung bei Belastungsinkontinenz. Gynäkologie, (4):31-36.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 4: Die Behandlung bei überaktiver Blase. Gynäkologie, (5):21-24.

Scheiner, D A; Betschart, C; Wiederkehr, S; Seifert, Burkhardt; Fink, D; Perucchini, D (2012). Twelve months effect on voiding function of retropubic compared with outside-in and inside-out transobturator midurethral slings. International Urogynecology Journal, 23(2):197-206.

Betschart, C; Perucchini, D; Scheiner, D (2011). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Gynäkologie, (2):11-14.

Betschart, C; Perucchini, D; Scheiner, D (2011). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Ars Medici, (15):619-623.

von Mandach, U; Betschart, C (2011). Bryophyllum pinnatum in der Geburtshilfe und Gynäkologie. Wirksamkeit und Verträglichkeit. info@gynäkologie, (3):16-20.

Betschart, C; Kerl, K; Fink, D (2011). Harninkontinenz macht nicht nur nass! Diagnose und Therapie lokaler Begleiterkrankungen der Harninkontinenz. Leading Opinions - Medizin für die Frau, 4:26-29.

Betschart, C (2011). Neue Therapieoptionen gegen verstärkte uterine Blutungen. Vorgehen bei Hypermenorrhoe. info@gynäkologie, (1):36-37.

Betschart, C; Scheiner, D; Hess, E; Seifert, Burkhardt; Fink, D; Perucchini, D (2011). Patient satisfaction after retropubic and transobturator slings: first assessment using the Incontinence Outcome Questionnaire (IOQ). International Urogynecology Journal, 22(7):805-812.

Betschart, C; Scheiner, D; Fink, D (2011). Reizblase bei der Frau: Neue Therapieansätze. Hausarzt Praxis, (8):30-32.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2011). TVT, TOT und TVT-O: Schweizer 1-Jahres-Resultate. Vergleich verschiedener Schlingen bei Inkontinenz. Leading Opinions - Medizin für die Frau, 4(3):26-29.

Betschart, C; Scheiner, D; Fink, D; Peruccini, D (2010). Overactive Bladder: Individuelles Stufenkonzept in Abklärung und Therapie. Leading Opinions. Medizin für die Frau, 3(2):18-20.

Scheiner, D; Betschart, C; Perucchini, D (2010). Altersabhängige Veränderungen des Beckenbodens bei der Frau. Therapeutische Umschau, 67(1):23-26.

Betschart, C; Scheiner, D; Fink, D (2010). Basisabklärung: Wann ist eine Urodynamik sinnvoll? : Diagnostik bei Harninkontinenz und Drangbeschwerden. Gynäkologie, (2):21-25.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2010). Langzeiterfahrung mit intravesikaler Botoxinjektion : Anwendung bei therapierefraktärer idiopathischer OAB-Symptomatik. Gynäkologie, (3):2-6.

Peruccini, D; Betschart, C; Fink, D; Scheiner, D (2010). Schlingenoperationen bei Belastungsinkontinenz: Reicht eine einzige Schlinge für alle Indikationen? Leading Opinions. Medizin für die Frau, 3(2):22-26.

Betschart, C; Perucchini, D (2010). Überaktive Blase: Management in der Praxis. Gynäkologie, (2):26-28.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2009). Anticholinerge Therapie der hyperaktiven Blase. Ars Medici, (3):18-23.

Betschart, C; Scheiner, D; Maake, C; Vich, M; Slomianka, L; Fink, D; Perucchini, D (2008). Histomorphological analysis of the urogenital diaphragm in elderly women: a cadaver study. International Urogynecology Journal, 19(11):1477-1481.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2008). Anticholinerge Therapie der hyperaktiven Blase: Wie wird optimiert? Gynäkologie, (5):23-28.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Das Urethralsyndrom: Prävalenz, Differenzialdiagnose,Therapie. Gynäkologie, (2):14-16.

Betschart, C; Scheiner, D; Fink, D; Perucchini, D (2008). Konservative Therapie von Harninkontinenz, Drangsymptomen und Genitaldeszensus. Journal für Urologie und Urogynäkologie, 15(3):23-30.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Moderne Schlingentechniken bei Belastungsinkontinenz: Technik, Studienresultate, Komplikationen, Differenzialindikation. Gynäkologie, (2):17-22.

Betschart, Cornelia

Schumpf, Lea F; Theill, Nathan; Scheiner, David A; Fink, Daniel; Riese, Florian; Betschart, Cornelia (2017). Urinary incontinence and its association with functional physical and cognitive health among female nursing home residents in Switzerland. BMC Geriatrics, 17(1):17.

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Betschart, Cornelia; Ghisu, Gian-Piero; Fink, Daniel (2016). Normale und abnorme kolposkopische Befunde. Praxis, 105(23):1363-1369.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Author's reply to letter from Matthes and Zucca-Matthes on "Quantitative analyses of variability in normal vaginal shape and dimension on MR images". International Urogynecology Journal and Pelvic Floor Dysfunction, 27(10):1611.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Blut im Urin, was nun? Abklärung der nicht-sichtbaren Hämaturie bei der Frau. Praxis, 105(19):1133-1141.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Quantitative analyses of variability in normal vaginal shape and dimension on MR images. International Urogynecology Journal and Pelvic Floor Dysfunction, 27(7):1087-1095.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Botox für die Blase. Leading Opinions - Gynäkologie & Geburtshilfe:25-29.

Baege, Astrid; Ghisu, Gian-Piero; Betschart, Cornelia; Fink, Daniel (2016). Die HPV-Impfung und -Typisierung in der Primär- und Sekundärprävention: Stellenwert in der Praxis. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):20-24.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Erythrozyten im Harn. Internistische Praxis:673-680.

Perucchini, Daniele; Scheiner, David A; Fink, Daniel; Betschart, Cornelia (2016). Management der Mischinkontinenz. Schritt für Schritt zum Erfolg – Diagnostik, Therapie, Beratung. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:15-20.

Betschart, Cornelia; Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2016). Normale und abnormale kolposkopische Befunde: Klassifikation und Bedeutung: Welche Befunde sind „gefährlich“? Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):6-13.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Rezidivierende Harnwegsinfekte : Komplikationen, Therapieoptionen, Prävention. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:6-14.

Ghisu, Gian-Piero; Baege, Astrid; Betschart, Cornelia; Fink, Daniel (2016). Therapie bei dysplastischen Veränderungen in der Gynäkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 4:14-19.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2016). Urininkontinenz und Sexualität. Hausarzt Praxis:2-4.

Vaso, Martin; Betschart, Cornelia; Egger, Herwig; Fink, Daniel; Schmidt, Ana-Maria (2015). Surgical technique of a recurrent post-radiation vesicovaginal fistula with a small intestine graft. Archives of Gynecology and Obstetrics, 292(3):485-488.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2015). Interstitial cystitis/bladder pain syndrome (IC/BPS). Praxis, 104(17):909-918.

Nikolopoulos, Kostis I; Betschart, Cornelia; Doumouchtsis, Stergios K (2015). The surgical management of recurrent stress urinary incontinence: a systematic review. Acta Obstetricia et Gynecologica Scandinavica, 94(6):568-576.

Kim, Jinyong; Betschart, Cornelia; Ramanah, Rajeev; Ashton-Miller, James A; DeLancey, John O L (2015). Anatomy of the pubovisceral muscle origin: Macroscopic and microscopic findings within the injury zone. Neurourology and Urodynamics, 34(8):774-780.

Sikora, Michal; Scheiner, David; Betschart, Cornelia; Perucchini, Daniele; Mateos, José María; di Natale, Anthony; Fink, Daniel; Maake, Caroline (2015). Label-free, three-dimensional multiphoton microscopy of the connective tissue in the anterior vaginal wall. International Urogynecology Journal and Pelvic Floor Dysfunction, 26(5):685-691.

Betschart, Cornelia; Kim, Jinyong; Miller, Janis M; Ashton-Miller, James A; DeLancey, John O L (2014). Comparison of muscle fiber directions between different levator ani muscle subdivisions: in vivo MRI measurements in women. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(9):1263-1268.

Betschart, Cornelia; Rizk, Diaa E E (2014). Climbing a long hill: pelvic floor surgery and the need for geriatric urogynecology. International urogynecology journal and pelvic floor dysfunction, 25(3):297-298.

Strutas, Deivis; Betschart, Cornelia; Fink, Daniel (2014). Das Vestibulitissyndrom. Gynäkologie, 4:25-19.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Erythrozyten im Harn. Wie ist das weitere Vorgehen? Gynaekologische Praxis, 38(2):271-279.

Luo, Jiajia; Betschart, Cornelia; Chen, Luyun; Ashton-Miller, James A; Delancey, John O L (2014). Using stress MRI to analyze the 3D changes in apical ligament geometry from rest to maximal Valsalva: a pilot study. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(2):197-203.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Vom Fettgift zum modernen Therapeutikum – Botulinumneurotoxine. info@gynäkologie, 5:20-22.

Betschart, Cornelia; Strutas, Deivis; Fink, Daniel (2014). Vulvadermatosen. Gynäkologie, 4:6-12.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Botox in der Schwangerschaft und der Stillzeit. Hebamme.ch = Sage-femme.ch = Levatrice.ch = Spendrera.ch, (6):14-16.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Deszensuschirurgie. Neue und bewährte Techniken. Gynäkologie, (5):6-11.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Die Belastungsinkontinenz. Diagnostik und Therapie. Gynäkologie, (5):12-17.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Die Bildgebung des Beckenbodens. Ultraschall und MRI. Gynäkologie, (5):23-26.

Perucchini, Daniele; Betschart, Cornelia; Scheiner, David; Fink, Daniel (2013). Die überaktive Blase. Differenzialdiagnostik und therapeutisches Management. Gynäkologie, (5):18-22.

Scheiner, David; Betschart, Cornelia; Perucchini, Daniele (2013). Aktueller Stellenwert der Netzchirurgie. Fortbildung Genitaldeszensus. info@gynäkologie, 1:6-8.

Nygaard, Christiana Campani; Betschart, Cornelia; Hafez, Ahmed A; Lewis, Erica; Chasiotis, Ilias; Doumouchtsis, Stergios K (2013). Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction, 24(12):2071-2076.

Scheiner, David; Maggi, N; Perucchini, Daniele; Betschart, Cornelia (2013). Keimbefall bei Frauen mit und ohne OAB. Prävalenz von Urea- und Mycoplasmen, Gonokokken und Chlamydien im Urethralabstrich. Urologische Nachrichten, 3:9.

Betschart, Cornelia; Mol, Suzanne E; Lütolf-Keller, Béatrice; Fink, Daniel; Perucchini, Daniele; Scheiner, David (2013). Pelvic floor muscle training for urinary incontinence: a comparison of outcomes in premenopausal versus postmenopausal women. Female Pelvic Medicine and Reconstructive Surgery, 19(4):219-224.

Betschart, Cornelia; von Mandach, Ursula; Seifert, Burkhardt; Scheiner, David; Perucchini, Daniele; Fink, Daniel; Geissbühler, Verena (2013). Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, 20(3-4):351-358.

Birindelli, Esther

Birindelli, Esther; Fink, Daniel (2015). Abnormal Early Pregnancy: What Matters for Practice. Praxis, 104(12):617-621.

Blank, P R

Blank, P R; Dedes, K J; Szucs, T D (2010). Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review. PharmacoEconomics, 28(8):629-647.

Blochlinger-Wegmann, B

Blochlinger-Wegmann, B; Werner, M; Scheiner, D; Fink, D; Perucchini, D (2008). Urethraldivertikel als Ursache chronischer urogenitaler Schmerzen: Ein Fallbericht. Gynäkologisch-Geburtshilfliche Rundschau, 48(1):35-37.

Boldt, Karsten

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Bonalli, Mario

Jungmichel, Stephanie; Clapperton, Julie A; Lloyd, Janette; Hari, Flurina J; Spycher, Christoph; Pavic, Lucijana; Li, Jiejin; Haire, Lesley F; Bonalli, Mario; Larsen, Dorthe H; Lukas, Claudia; Lukas, Jiri; MacMillan, Derek; Nielsen, Michael L; Stucki, Manuel; Smerdon, Stephen J (2012). The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator. Nucleic Acids Research, 40(9):3913-3928.

Bonnefoi, H

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Bootz, F

Schwager, K; Bootz, F; Imesch, P; Kaspar, M; Trachsel, E; Neri, D (2011). The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Human Reproduction, 26(9):2344-2352.

Boss, Andreas

Wiederer, Julia; Pazahr, Shila; Leo, Cornelia; Nanz, Daniel; Boss, Andreas (2014). Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue. Magma, 27(2):185-193.

Bovin, N

Pochechueva, T; Chinarev, A; Spengler, M; Korchagina, E; Heinzelmann-Schwarz, V; Bovin, N; Rieben, R (2011). Multiplex suspension array for human anti-carbohydrate antibody profiling. The Analyst, 136(3):560-569.

Bovin, N V

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Bowman, A

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Bracone, Gabriela

Scheiner, David; Bracone, Gabriela; Imesch, Patrick; Fink, Daniel; Imthurn, Bruno (2016). Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue. Journal of Ovarian Research, 9(1):59.

Brandner, S

Brandner, S. Laparoskopische Sakropexie – prospektive Fallkontrollstudie von 90 an der Frauenklinik des Kantonsspital Aarau operierten Patientinnen. 2008, University of Zurich, Faculty of Medicine.

Brandt, Simone

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Brauchli, P

Matter-Walstra, K W; Dedes, K J; Schwenkglenks, M; Brauchli, P; Szucs, T D; Pestalozzi, B C (2010). Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21(11):2161-2168.

Dedes, K J; Matter-Walstra, K; Schwenkglenks, M; Pestalozzi, B C; Fink, D; Brauchli, P; Szucs, T D (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation. European Journal of Cancer, 45(8):1397-1406.

Braumann, U D

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Brioschi, P A

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Bronz, L

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Brough, R

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Buehler, Michelle

Buehler, Michelle. Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer. 2014, University of Zurich, Faculty of Medicine.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Burger, D

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Burger, I A

Burger, I A; Scheiner, D A; Crook, D W; Treyer, V; Hany, T F; von Schulthess, G K (2011). FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position. European Journal of Nuclear Medicine and Molecular Imaging, 38(1):90-96.

Burges, A

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Bénard, S

Szucs, T D; Largeron, N; Dedes, K J; Rafia, R; Bénard, S (2008). Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Current Medical Research and Opinion, 24(5):1473-1483.

Caduff, R

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Noske, A; Zimmermann, A K; Caduff, R; Varga, Z; Fink, D; Moch, H; Kristiansen, G (2011). Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Archiv, 459(1):91-97.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Giobbie-Hurder, A; Price, K N; Gelber, R D; et al; Varga, Z; Moch, H; Caduff, R (2009). Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical Trials, 6(3):272-287.

Niederer, P; Weiss, S; Caduff, R; Bajka, M; Szekély, G; Harders, M (2009). Uterus models for use in virtual reality hysteroscopy simulators. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144, S:S90-S95.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Weiss, S; Niederer, P; Navarini, A; Caduff, R; Bajka, M (2008). Inverse finite element characterization of the human myometrium derived from uniaxial compression experiments. Biomedizinische Technik. Biomedical Engineering, 53(2):52-58.

Caduff, Rosemarie

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Caduff, Rosmarie

Schraag, Sabrina M; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Schmidt, Ana-Maria (2017). Uterine tumors resembling ovarian sex cord tumors: treatment, recurrence, pregnancy and brief review. Gynecologic Oncology Reports, 19:53-56.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Samartzis, Nicolas; Samartzis, Eleftherios P; Noske, Aurelia; Fedier, Andre; Dedes, Konstantin J; Caduff, Rosmarie; Fink, Daniel; Imesch, Patrick (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology, 10:30.

Samartzis, Eleftherios P; Samartzis, Nicolas; Noske, Aurelia; Fedier, André; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2012). Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? Modern Pathology, 25(6):885-892.

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs; Fehr, Mathias (2003). Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study. Lasers in surgery and medicine, 33(3):209-212.

Wyss, Pius; Caduff, Rosmarie; Tadir, Yona; Degen Iseli, Andrea Franziska; Wagnières, Georges; Schwarz, Viola; Haller, Urs; Fehr, Mathias (2003). Photodynamic endometrial ablation: morphological study. Lasers in surgery and medicine, 32(4):305-309.

Campone, M

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Candia, V

Kut, E; Candia, V; von Overbeck, J; Pok, J; Fink, D; Folkers, G (2011). Pleasure-related analgesia activates opioid-insensitive circuits. Journal of Neuroscience, 31(11):4148-53.

Canonica, C

Leimbacher, B; Samartzis, N; Imesch, P; Dedes, K J; Fink, D; Canonica, C (2012). Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. Archives of Gynecology and Obstetrics, 285(5):1441-1445.

Canzler, U

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Carey, M S

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Castiglione-Gertsch, M

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Cerone, M A

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Cervantes, A

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Cervigni, Mauro

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Chaloupka, Karla

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Charpidou, Theodosia

Charpidou, Theodosia; Lang, Franziska; Langenegger, Thomas; Dedes, Konstantin J; Honegger, Christoph (2013). Bilateral transient osteoporosis of the knee during pregnancy. Archives of Gynecology and Obstetrics, 287(6):1259-1261.

Chasiotis, Ilias

Nygaard, Christiana Campani; Betschart, Cornelia; Hafez, Ahmed A; Lewis, Erica; Chasiotis, Ilias; Doumouchtsis, Stergios K (2013). Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction, 24(12):2071-2076.

Chen, L

Betschart, C; Chen, L; Ashton-Miller, J A; Delancey, J O L (2013). On pelvic reference lines and the MR evaluation of genital prolapse: a proposal for standardization using the Pelvic Inclination Correction System. International urogynecology journal and pelvic floor dysfunction, 24(9):1421-1428.

Chen, Luyun

Luo, Jiajia; Betschart, Cornelia; Chen, Luyun; Ashton-Miller, James A; Delancey, John O L (2014). Using stress MRI to analyze the 3D changes in apical ligament geometry from rest to maximal Valsalva: a pilot study. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(2):197-203.

Chen, Y T

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Chinarev, A

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Pochechueva, T; Chinarev, A; Spengler, M; Korchagina, E; Heinzelmann-Schwarz, V; Bovin, N; Rieben, R (2011). Multiplex suspension array for human anti-carbohydrate antibody profiling. The Analyst, 136(3):560-569.

Chirgwin, J

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Chis, Carmen

Panel, Pierre; Bajka, Michael; Le Tohic, Arnaud; Ghoneimi, Alaa El; Chis, Carmen; Cotin, Stéphane (2012). Hysteroscopic placement of tubal sterilization implants: virtual reality simulator training. Surgical Endoscopy, 26(7):1986-1996.

Church, D N

Church, D N; Koppensteiner, R; Yap, T; Fink, Daniel; Dedes, K J (2012). P13K-AKT-mTOR inhibitors for the systematic treatment of endometrial cancer. Expert Review of Obstetrics & Gynecology, 7(5):421-430.

Clancy, J L

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Clapperton, Julie A

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Jungmichel, Stephanie; Clapperton, Julie A; Lloyd, Janette; Hari, Flurina J; Spycher, Christoph; Pavic, Lucijana; Li, Jiejin; Haire, Lesley F; Bonalli, Mario; Larsen, Dorthe H; Lukas, Claudia; Lukas, Jiri; MacMillan, Derek; Nielsen, Michael L; Stucki, Manuel; Smerdon, Stephen J (2012). The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator. Nucleic Acids Research, 40(9):3913-3928.

Clavien, P A

Müller, M K; Dedes, K J; Dindo, D; Steiner, S; Hahnloser, D; Clavien, P A (2009). Impact of clinical pathways in surgery. Langenbeck's Archives of Surgery, 394(1):31-39.

Coates, A

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Coates, A S

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Colleoni, M

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Collinson, F

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Contreras Ortiz, Oscar

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Corpet, Armelle

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Corpet, Armelle; Stucki, Manuel (2014). Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells. Chromosoma, 123(5):423-436.

Corpet, Armelle; Olbrich, Teresa; Gwerder, Myriam; Fink, Daniel; Stucki, Manuel (2014). Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle, 13(2):0-18.

Abascal, Federico; Corpet, Armelle; Gurard-Levin, Zachary A; Juan, David; Ochsenbein, Françoise; Rico, Daniel; Valencia, Alfonso; Almouzni, Geneviève (2013). Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution, 30(8):1853-1866.

Costa-Cabral, S

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Cotin, Stéphane

Panel, Pierre; Bajka, Michael; Le Tohic, Arnaud; Ghoneimi, Alaa El; Chis, Carmen; Cotin, Stéphane (2012). Hysteroscopic placement of tubal sterilization implants: virtual reality simulator training. Surgical Endoscopy, 26(7):1986-1996.

Crook, D W

Burger, I A; Scheiner, D A; Crook, D W; Treyer, V; Hany, T F; von Schulthess, G K (2011). FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position. European Journal of Nuclear Medicine and Molecular Imaging, 38(1):90-96.

Dacheva, T P

Dacheva, T P. Prävalenz HPV bedingter anogenitaler Veränderungen bei lungentransplantierten Patientinnen. 2010, University of Zurich, Faculty of Medicine.

Daley, Frances

Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; Töpfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.

Davies, M J

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

De Geyter, C

Mueller, M; Eberhard, M; De Geyter, C; Häberlin, F; Hohl, M K; Imesch, P; Polli, C; Possover, M; Schiessl, K; Wenger, J M; Wunder, D (2012). Diagnostik und Therapie der Endometriose. Frauenheilkunde Aktuell, 21(2):28-34.

DeLancey, John O L

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Author's reply to letter from Matthes and Zucca-Matthes on "Quantitative analyses of variability in normal vaginal shape and dimension on MR images". International Urogynecology Journal and Pelvic Floor Dysfunction, 27(10):1611.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Quantitative analyses of variability in normal vaginal shape and dimension on MR images. International Urogynecology Journal and Pelvic Floor Dysfunction, 27(7):1087-1095.

Kim, Jinyong; Betschart, Cornelia; Ramanah, Rajeev; Ashton-Miller, James A; DeLancey, John O L (2015). Anatomy of the pubovisceral muscle origin: Macroscopic and microscopic findings within the injury zone. Neurourology and Urodynamics, 34(8):774-780.

Betschart, Cornelia; Kim, Jinyong; Miller, Janis M; Ashton-Miller, James A; DeLancey, John O L (2014). Comparison of muscle fiber directions between different levator ani muscle subdivisions: in vivo MRI measurements in women. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(9):1263-1268.

Dedes, I

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Dedes, Ioannis

Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; Töpfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Dedes, J

Dedes, J. Acquired vorinostat resistance shows partial cross-resistance to "second-generation" HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. 2010, University of Zurich, Faculty of Medicine.

Dedes, K

Dedes, K; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane. Vulvakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 399-400.

Dedes, K; Pestalozzi, B; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Ovarial- und Tubenkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 385-390.

Schnabel, J; Heuer, H; Dedes, K; Fink, D (2014). Hochrisikokonstellation für Brustkrebs. Schweizer Zeitschrift für Onkologie, 3:28-32.

Imesch, P; Dedes, K; Fink, D (2009). Laparoskopische Therapie des Korpuskarzinoms: Datenlage und Evidenz. Gynäkologisch-geburtshilfliche Rundschau, 49(3):111-116.

Dedes, K J

Matter-Walstra, Klazien; Ruhstaller, T; Klingbiel, D; Schwenkglenks, Matthias; Dedes, K J (2016). Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK). Breast Cancer Research and Treatment, 158(1):51-57.

Leimbacher, B; Samartzis, N; Imesch, P; Dedes, K J; Fink, D; Canonica, C (2012). Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. Archives of Gynecology and Obstetrics, 285(5):1441-1445.

Church, D N; Koppensteiner, R; Yap, T; Fink, Daniel; Dedes, K J (2012). P13K-AKT-mTOR inhibitors for the systematic treatment of endometrial cancer. Expert Review of Obstetrics & Gynecology, 7(5):421-430.

Dedes, K J; Fink, Daniel; Steiner, R A (2012). Principes de la chimiothérapie. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 50-54.

Dedes, K J; Natrajan, R; Lambros, M B; Geyer, F C; Lopez-Garcia, M A; Savage, K; Jones, R L; Reis-Filho, J S (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. European Journal of Cancer, 47(1):138-150.

Dedes, K J; Wetterskog, D; Ashworth, A; Kaye, S B; Reis-Filho, J S (2011). Emerging therapeutic targets in endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):261-271.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Wilkerson, P M; Dedes, K J; Wetterskog, D; Mackay, A; Lambros, M B; Mansour, M; Frankum, J; Lord, C J; Natrajan, R; Ashworth, A; Reis-Filho, J S (2011). Functional characterization of EMSY gene amplification in human cancers. Journal of Pathology, 225(1):29-42.

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Dedes, K J; Fink, D (2011). Ovarial-, Zervix- und Vulvakarzinom: Neues zu gynäkologischen Tumoren. Hausarzt Praxis, 8(15):15-18.

Papadatos-Pastos, D; Dedes, K J; de Bono, J S; Kaye, S B (2011). Revisiting the role of antiandrogen strategies in ovarian cancer. The Oncologist, 16(10):1413-1421.

Dedes, K J; Wilkerson, P M; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, J S (2011). Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle, 10(8):1192-1199.

Dedes, K J; Fink, D; Steiner, R (2011). Systemische Tumorkontrolle: Chemotherapeutische Prinzipien. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 47-52.

Forster, M D; Dedes, K J; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C J; Weigelt, B; Kaye, S B; Rhoda Molife, L (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):302-306.

Dedes, K J; Lopez-Garcia, M A; Geyer, F C; Lambros, M B K; Savage, K; Vatcheva, R; Wilkerson, P; Wetterskog, D; Lacroix-Triki, M; Natrajan, R; Reis-Filho, J S (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment, 124(3):653-666.

Blank, P R; Dedes, K J; Szucs, T D (2010). Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review. PharmacoEconomics, 28(8):629-647.

Lambros, M B; Natrajan, R; Geyer, F C; Lopez-Garcia, M A; Dedes, K J; Savage, K; Lacroix-Triki, M; Jones, R L; Lord, C J; Linardopoulos, S; Ashworth, A; Reis-Filho, J S (2010). PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Modern Pathology, 23(10):1334-1345.

Dedes, K J; Wetterskog, D; Mendes-Pereira, A M; Natrajan, R; Lambros, M B; Geyer, F C; Vatcheva, R; Savage, K; Mackay, A; Lord, C J; Ashworth, A; Reis-Filho, J S (2010). PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Science Translational Medicine, 2(53):53ra75.

Matter-Walstra, K W; Dedes, K J; Schwenkglenks, M; Brauchli, P; Szucs, T D; Pestalozzi, B C (2010). Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21(11):2161-2168.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Dedes, K J; Matter-Walstra, K; Schwenkglenks, M; Pestalozzi, B C; Fink, D; Brauchli, P; Szucs, T D (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation. European Journal of Cancer, 45(8):1397-1406.

Müller, M K; Dedes, K J; Dindo, D; Steiner, S; Hahnloser, D; Clavien, P A (2009). Impact of clinical pathways in surgery. Langenbeck's Archives of Surgery, 394(1):31-39.

Dedes, K J; Fink, D (2009). Clinical Presentation and Surgical Management of Invasive Lobular Carcinoma of the Breast. Breast Disease, 30:31-37.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Szucs, T D; Largeron, N; Dedes, K J; Rafia, R; Bénard, S (2008). Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Current Medical Research and Opinion, 24(5):1473-1483.

Dedes, K J; Gabriel, N; Fink, D (2008). Aktuelle adjuvante endokrine Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):130-137.

Szucs, T D; Dedes, K J (2008). Balancing costs and benefits in cancer therapy and prevention. Annals of Oncology, 19(Suppl.):vii313-vii319.

Dedes, K J; Beneder, C; Samartzis, N; Muller, M D; Fink, D; Fehr, M K (2008). Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. Journal of Reproductive Medicine, 53(12):947-951.

Dedes, Konstantin

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Dedes, Konstantin J

Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; Töpfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.

Schraag, Sabrina M; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Schmidt, Ana-Maria (2017). Uterine tumors resembling ovarian sex cord tumors: treatment, recurrence, pregnancy and brief review. Gynecologic Oncology Reports, 19:53-56.

Dedes, Konstantin J; Fink, Daniel (2016). Mammakarzinom in der Schwangerschaft. info@gynäkologie, 6:18-21.

Hempen, Aline; Samartzis, Eleftherios P; Kamarachev, Jivko; Fink, Daniel; Dedes, Konstantin J (2015). Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report. BMC Cancer, 15(507):online.

Ihnenfeld Arciénega, Isabel; Imesch, Patrick; Fink, Daniel; Dedes, Konstantin J (2015). Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature. Targeted oncology, 10(2):297-301.

Samartzis, Eleftherios P; Gutsche, Katrin; Dedes, Konstantin J; Fink, Daniel; Stucki, Manuel; Imesch, Patrick (2014). Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. OncoTarget, 5(14):5295-5303.

Natrajan, R; Wilkerson, P M; Marchiò, C; Piscuoglio, Salvatore; Lambros, M B; Samartzis, Eleftherios P; Dedes, Konstantin J (2014). Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. Journal of Pathology, 232(5):553-565.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Samartzis, Eleftherios P; Noske, Aurelia; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2013). ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. International Journal of Molecular Sciences, 14(9):18824-18849.

Imesch, Patrick; Samartzis, Eleftherios P; Dedes, Konstantin J; Fink, Daniel; Fedier, André (2013). Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells. Fertility and Sterility, 100(3):770-776.

Charpidou, Theodosia; Lang, Franziska; Langenegger, Thomas; Dedes, Konstantin J; Honegger, Christoph (2013). Bilateral transient osteoporosis of the knee during pregnancy. Archives of Gynecology and Obstetrics, 287(6):1259-1261.

Samartzis, Nicolas; Samartzis, Eleftherios P; Noske, Aurelia; Fedier, Andre; Dedes, Konstantin J; Caduff, Rosmarie; Fink, Daniel; Imesch, Patrick (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology, 10:30.

Samartzis, Eleftherios P; Samartzis, Nicolas; Noske, Aurelia; Fedier, André; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2012). Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? Modern Pathology, 25(6):885-892.

Szucs, Thomas D; Dedes, Konstantin J (2009). Is cancer prevention ever going to be profitable? In: Senn, H J; Kapp, U; Ott, F. Cancer Prevention II. Berlin: Springer, 41-47.

Dedes, Konstantin J.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Defazio, A

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Degen Iseli, Andrea Franziska

Degen Iseli, Andrea Franziska; Gabrecht, Tanja; Mosimann, Laurent; Fehr, Mathias K; Hornung, René; Schwarz, Viola A; Tadir, Yona; Steiner, Rolf A; Wagnières, Georges; Wyss, Pius (2004). Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers in surgery and medicine, 34(1):1-4.

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs; Fehr, Mathias (2003). Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study. Lasers in surgery and medicine, 33(3):209-212.

Wyss, Pius; Caduff, Rosmarie; Tadir, Yona; Degen Iseli, Andrea Franziska; Wagnières, Georges; Schwarz, Viola; Haller, Urs; Fehr, Mathias (2003). Photodynamic endometrial ablation: morphological study. Lasers in surgery and medicine, 32(4):305-309.

Fehr, Mathias K; Hornung, René; Degen Iseli, Andrea Franziska; Schwarz, Viola A; Fink, Daniel; Haller, Urs; Wyss, Pius (2002). Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers in surgery and medicine, 30(4):273-279.

Del Prete, Valerio

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Delaloye, J F

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Delancey, J O L

Betschart, C; Chen, L; Ashton-Miller, J A; Delancey, J O L (2013). On pelvic reference lines and the MR evaluation of genital prolapse: a proposal for standardization using the Pelvic Inclination Correction System. International urogynecology journal and pelvic floor dysfunction, 24(9):1421-1428.

Delancey, John O L

Luo, Jiajia; Betschart, Cornelia; Chen, Luyun; Ashton-Miller, James A; Delancey, John O L (2014). Using stress MRI to analyze the 3D changes in apical ligament geometry from rest to maximal Valsalva: a pilot study. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(2):197-203.

Dellas, Athanassios

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Denhaerynck, Kris

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Deprest, Jan

Mazza, Edoardo; Parra-Saavedra, Miguel; Bajka, Michael; Gratacos, Eduard; Nicolaides, Kypros; Deprest, Jan (2014). In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy. Prenatal Diagnosis, 34(1):33-41.

Diebold, Joachim

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Dietel, M

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Dietrich, D

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Dindo, D

Müller, M K; Dedes, K J; Dindo, D; Steiner, S; Hahnloser, D; Clavien, P A (2009). Impact of clinical pathways in surgery. Langenbeck's Archives of Surgery, 394(1):31-39.

Djouder, N

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Doumouchtsis, Stergios K

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Nikolopoulos, Kostis I; Betschart, Cornelia; Doumouchtsis, Stergios K (2015). The surgical management of recurrent stress urinary incontinence: a systematic review. Acta Obstetricia et Gynecologica Scandinavica, 94(6):568-576.

Nygaard, Christiana Campani; Betschart, Cornelia; Hafez, Ahmed A; Lewis, Erica; Chasiotis, Ilias; Doumouchtsis, Stergios K (2013). Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction, 24(12):2071-2076.

Dubey, R K

Samartzis, E; Imesch, P; Twiehaus, A; Dubey, R K; Leeners, Brigitte (2016). The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen receptor independent manner. Gynecological Endocrinology, 32(7):529-533.

Barchiesi, F; Lucchinetti, E; Zaugg, M; Ogunshola, O O; Wright, M; Meyer, Markus; Rosselli, M; Schaufelberger, S; Gillespie, D G; Jackson, E K; Dubey, R K (2010). Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension, 56(5):964-972.

Dubey, Raghvendra

Imesch, Patrick; Scheiner, David; Xie, Min; Fink, Daniel; Macas, Erwin; Dubey, Raghvendra; Imthurn, Bruno (2013). Developmental potential of human oocytes matured in vitro followed by vitrification and activation. Journal of Ovarian Research, 6:30.

Dubuisson, J B

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Dummer, Reinhard

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Eberhard, J

Viereck, V; Eberhard, J (2008). Inkontinenzoperationen - Indikationen, Auswahl der Operationsmethode, Operationstechnik, Umgang mit Früh- und Spätkomplikationen. Journal für Urologie und Urogynäkologie, 15(3):37-42.

Kociszewski, J; Rautenberg, O; Perucchini, D; Eberhard, J; Geissbühler, V; Hilgers, R; Viereck, V (2008). Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourology and Urodynamics, 27(6):485-490.

Eberhard, J (2008). Urogenitale Beschwerden - Häufige Frauenleiden. Journal für Urologie und Urogynäkologie, 15(3):4-5.

Eberhard, M

Mueller, M; Eberhard, M; De Geyter, C; Häberlin, F; Hohl, M K; Imesch, P; Polli, C; Possover, M; Schiessl, K; Wenger, J M; Wunder, D (2012). Diagnostik und Therapie der Endometriose. Frauenheilkunde Aktuell, 21(2):28-34.

Egger, H

Schmidt, A-M; Imesch, P; Fink, Daniel; Egger, H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecologic oncology, 125(3):604-609.

Egger, Herwig

Schmidt, Ana-Maria; Imesch, Patrick; Fink, Daniel; Egger, Herwig (2016). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients. International Journal of Gynecological Cancer, 26(4):716-721.

Vaso, Martin; Betschart, Cornelia; Egger, Herwig; Fink, Daniel; Schmidt, Ana-Maria (2015). Surgical technique of a recurrent post-radiation vesicovaginal fistula with a small intestine graft. Archives of Gynecology and Obstetrics, 292(3):485-488.

Eicher, Manuela

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Einarsson, R

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Einenkel, J

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Ejlertsen, B

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Ellensohn, V F

Ellensohn, V F. Kurz- und mittelfristige Ergebnisse der TVT-Implantation an der Frauenklinik des Kantonsspitals St. Gallen. 2008, University of Zurich, Faculty of Medicine.

Emons, G

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Engberg, Sandra

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Essapen, S

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Fankhauser, Niklaus

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Favier, J

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Fedier, A

Imesch, P; Hornung, R; Fink, D; Fedier, A (2011). Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecologic and Obstetric Investigation, 72(1):43-49.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Imesch, P; Samartzis, E P; Schneider, M; Fink, D; Fedier, A (2011). Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertility and Sterility, 95(5):1579-1583.

Imesch, P; Goehrens, A; Fink, D; Fedier, A (2011). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine)in vitro. Oncology Letters, 3(2):441-444.

Imesch, P; Fink, D; Fedier, A (2010). Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertility and Sterility, 94(7):2838-2842.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Fedier, A. Strategies for prevention, circumvention, and reversal of drug resistance in tumor cells. 2008, University of Zurich, Faculty of Medicine.

Fedier, Andre

Samartzis, Nicolas; Samartzis, Eleftherios P; Noske, Aurelia; Fedier, Andre; Dedes, Konstantin J; Caduff, Rosmarie; Fink, Daniel; Imesch, Patrick (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology, 10:30.

Fedier, André

Imesch, Patrick; Samartzis, Eleftherios P; Dedes, Konstantin J; Fink, Daniel; Fedier, André (2013). Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells. Fertility and Sterility, 100(3):770-776.

Imesch, Patrick; Scheiner, David; Szabo, Emese; Fink, Daniel; Fedier, André (2013). Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells. Experimental and Therapeutic Medicine, 6(3):786-790.

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Samartzis, Eleftherios P; Samartzis, Nicolas; Noske, Aurelia; Fedier, André; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2012). Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? Modern Pathology, 25(6):885-892.

Schneider-Yin, Xiaoye; Kurmanaviciene, Aida; Roth, Marion; Roos, Malgorzata; Fedier, André; Minder, Elisabeth I; Walt, Heinrich (2009). Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis and Photodynamic Therapy, 6(1):12-18.

Fehr, M

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Fehr, M K

Fink, D; Fehr, M K (2011). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 133-140.

Fehr, M K; Fink, D (2011). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 57-62.

Fehr, M K; Fink, D (2011). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch Gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 40-55.

Fehr, M K; Fink, D (2011). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 64-69.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Fehr, M K; Fink, D (2009). Karzinosarkome des Uterus, maligne Müller-Mischtumoren des Uterus, Maligne mesodermale Mischtumoren, Maligne gemischte mesenchymale Tumoren (MMMT). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 53-58.

Fehr, M K; Fink, D (2009). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 33-51.

Fink, D; Fehr, M K (2009). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 133-141.

Fehr, M K; Fink, D (2009). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 59-65.

Dedes, K J; Beneder, C; Samartzis, N; Muller, M D; Fink, D; Fehr, M K (2008). Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. Journal of Reproductive Medicine, 53(12):947-951.

Fehr, Mathias

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 57-62.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 37-56.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heildelberg: Springer Verlag, 65-70.

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs; Fehr, Mathias (2003). Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study. Lasers in surgery and medicine, 33(3):209-212.

Wyss, Pius; Caduff, Rosmarie; Tadir, Yona; Degen Iseli, Andrea Franziska; Wagnières, Georges; Schwarz, Viola; Haller, Urs; Fehr, Mathias (2003). Photodynamic endometrial ablation: morphological study. Lasers in surgery and medicine, 32(4):305-309.

Fehr, Mathias K

Lohri, Corinne; Hutzli Schaltegger, Claudia S; van den Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Research, 34:4693-4700.

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Degen Iseli, Andrea Franziska; Gabrecht, Tanja; Mosimann, Laurent; Fehr, Mathias K; Hornung, René; Schwarz, Viola A; Tadir, Yona; Steiner, Rolf A; Wagnières, Georges; Wyss, Pius (2004). Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers in surgery and medicine, 34(1):1-4.

Fehr, Mathias K; Hornung, René; Degen Iseli, Andrea Franziska; Schwarz, Viola A; Fink, Daniel; Haller, Urs; Wyss, Pius (2002). Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers in surgery and medicine, 30(4):273-279.

Feltovich, Helen

Myers, Kristin M; Feltovich, Helen; Mazza, Edoardo; Vink, Joy; Bajka, Michael; Wapner, Ronald J; Hall, Timothy J; House, Michael (2015). The mechanical role of the cervix in pregnancy. Journal of Biomechanics, 48(9):1511-1523.

Ferrero, A

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Fink, D

Pestalozzi, B; Fink, D (2016). Aszites. In: Kreuzer, Karl-Anton; Beyer, Jörg. Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Stuttgart: George Thieme Verlag, 88-89.

Leo, C; Fink, D (2016). Knoten in der Brust. In: Kreuzer, Karl-Anton; Beyer, Jörg. Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Stuttgart: George Thieme Verlag, 86-88.

Dedes, K; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane. Vulvakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 399-400.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Endometriumkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 390-394.

Dedes, K; Pestalozzi, B; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Ovarial- und Tubenkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 385-390.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Zervixkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 395-399.

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Schnabel, J; Heuer, H; Dedes, K; Fink, D (2014). Hochrisikokonstellation für Brustkrebs. Schweizer Zeitschrift für Onkologie, 3:28-32.

Kohl Schwartz, A S; Leo, C; Rufibach, Kaspar; Varga, Z; Fink, D; Gabriel, N (2013). Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure? European Journal of Surgical Oncology, 39(3):266-272.

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Fink, D (2012). Das Chamäleon unter den gynäkologischen Erkrankungen. Gynäkologie, (3):1.

Imesch, P; Fink, D (2012). Fertilitätserhaltende Therapien bei Ovarial- und Borderline-Tumoren. Leading Opinions Hämatologie & Onkologie, (5):52-54.

Fink, D (2012). Gatekeeper Frauenarztpraxis. Gynäkologie, (5):1.

Leimbacher, B; Samartzis, N; Imesch, P; Dedes, K J; Fink, D; Canonica, C (2012). Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. Archives of Gynecology and Obstetrics, 285(5):1441-1445.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Gynäkologie, (3):17-21.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Ars Medici, (18):934-937.

Imesch, P; Fink, D (2012). Nachsorge in de gynäkologischen Onkologie. Gynäkologie, (5):6-9.

Samartzis, E P; Imesch, P; Fink, D (2012). Pathogenese der Endometriose. Gynäkologie, (3):6-10.

Imesch, P; Samartzis, E P; Fink, D (2012). Prävalenz, Diagnostik und Therapie der Endometriose. info@gynäkologie, (3):19-21.

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Fink, D (2012). Therapie des Ovarialkarzinoms. Leading Opinions Medizin für die Frau, (3):31-32.

Scheiner, D A; Betschart, C; Wiederkehr, S; Seifert, Burkhardt; Fink, D; Perucchini, D (2012). Twelve months effect on voiding function of retropubic compared with outside-in and inside-out transobturator midurethral slings. International Urogynecology Journal, 23(2):197-206.

Imesch, P; Fink, D; Gabriel, N (2012). Was bringt ein Screening beim Ovarial- und Korpus-Ca? Leading Opinions Medizin für die Frau, (3):28-30.

Fink, D; Fehr, M K (2011). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 133-140.

Fehr, M K; Fink, D (2011). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 57-62.

Fehr, M K; Fink, D (2011). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch Gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 40-55.

Fehr, M K; Fink, D (2011). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 64-69.

Noske, A; Zimmermann, A K; Caduff, R; Varga, Z; Fink, D; Moch, H; Kristiansen, G (2011). Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Archiv, 459(1):91-97.

Fink, D (2011). Beratung zur Prävention – stetiger Diskussionsstoff. Gynäkologie, (4):1.

Achtari, C; Fink, D; Günthert, A R; Huober, J; Pestalozzi, B; Petignat, P; von Moos, R; Sessa, C (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer – some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 35(1):35-38.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Imesch, P; Hornung, R; Fink, D; Fedier, A (2011). Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecologic and Obstetric Investigation, 72(1):43-49.

Imesch, P; Samartzis, E P; Fink, D (2011). Endometriose - eine epigenetische Erkrankung? Leading Opinions - Medizin für die Frau, 4(1):2-4.

Leo, C; Fink, D (2011). Epithelial-zu-mesenchymale Transition (EMT) - Neue molekulare Einsichten in die Tumorprogression. Geburtshilfe und Frauenheilkunde, 71(01):21-25.

Leo, C; Fink, D (2011). Erythropoietin in der onkologischen Therapie – was wissen wir über die Risiken? Praxis, 100(20):1239-46.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Betschart, C; Kerl, K; Fink, D (2011). Harninkontinenz macht nicht nur nass! Diagnose und Therapie lokaler Begleiterkrankungen der Harninkontinenz. Leading Opinions - Medizin für die Frau, 4:26-29.

Imesch, P; Samartzis, E P; Schneider, M; Fink, D; Fedier, A (2011). Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertility and Sterility, 95(5):1579-1583.

Fink, D; Hutzli Schaltegger, C (2011). Intraoperative Radiotherapie: Neue Therapieoption beim Mammakarzinom. Kongress Special, (5-6):9.

Gabriel, N; Fink, D (2011). Lifestyleänderungen nach Mammakarzinom. Empfohlene Massnahmen und Fragen in der Beratung. Gynäkologie, (4):6-9.

Imesch, P; Goehrens, A; Fink, D; Fedier, A (2011). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine)in vitro. Oncology Letters, 3(2):441-444.

Fink, D (2011). Mamma-Screening: Ältere Studien sprechen dafür, neue warnen. Kongress Special, (3-4):9.

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Dedes, K J; Fink, D (2011). Ovarial-, Zervix- und Vulvakarzinom: Neues zu gynäkologischen Tumoren. Hausarzt Praxis, 8(15):15-18.

Betschart, C; Scheiner, D; Hess, E; Seifert, Burkhardt; Fink, D; Perucchini, D (2011). Patient satisfaction after retropubic and transobturator slings: first assessment using the Incontinence Outcome Questionnaire (IOQ). International Urogynecology Journal, 22(7):805-812.

Kut, E; Candia, V; von Overbeck, J; Pok, J; Fink, D; Folkers, G (2011). Pleasure-related analgesia activates opioid-insensitive circuits. Journal of Neuroscience, 31(11):4148-53.

Leo, C; Fink, D (2011). Prävention und Screening beim Mammakarzinom. Pro und Kontra des Mammografiescreenings. Schweizer Zeitschrift für Onkologie, (3):6-9.

Betschart, C; Scheiner, D; Fink, D (2011). Reizblase bei der Frau: Neue Therapieansätze. Hausarzt Praxis, (8):30-32.

Fink, D; Leo, C (2011). Synopsis grösserer Studien zur Therapie des metastasierten Mammakarzinoms. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 70-79.

Dedes, K J; Fink, D; Steiner, R (2011). Systemische Tumorkontrolle: Chemotherapeutische Prinzipien. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 47-52.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2011). TVT, TOT und TVT-O: Schweizer 1-Jahres-Resultate. Vergleich verschiedener Schlingen bei Inkontinenz. Leading Opinions - Medizin für die Frau, 4(3):26-29.

Imesch, P; Fink, D (2011). Zervixkarzinom. Therapeutische Umschau, 68(10):545-552.

Gabriel, N; Fink, D (2010). 32nd San Antonio Breast Cancer Symposium: Highlights aus San Antonio. Leading Opinions. Medizin für die Frau, 3(2):39-40.

Betschart, C; Scheiner, D; Fink, D; Peruccini, D (2010). Overactive Bladder: Individuelles Stufenkonzept in Abklärung und Therapie. Leading Opinions. Medizin für die Frau, 3(2):18-20.

Fink, D (2010). Therapie des Mammakarzinoms – Wandel von der radikalen zur qualitätskontrollierten individualisierten Therapie. Praxis, 99(7):397-398.

Betschart, C; Scheiner, D; Fink, D (2010). Basisabklärung: Wann ist eine Urodynamik sinnvoll? : Diagnostik bei Harninkontinenz und Drangbeschwerden. Gynäkologie, (2):21-25.

Imesch, P; Samartzis, E P; Fink, D (2010). Endometriose – eine epigenetische Erkrankung? Endometriose Aktuell, (2):2-4.

Imesch, P; Fink, D (2010). Endometriose: Richtiges operatives Vorgehen bei unerfülltem Kinderwunsch. Leading Opinions. Medizin für die Frau, 3(3):10-12.

Bajka, M; Tuchschmid, S; Fink, D; Székely, G; Harders, M (2010). Establishing construct validity of a virtual-reality training simulator for hysteroscopy via a multimetric scoring system. Surgical Endoscopy, 24(1):79-88.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2010). Langzeiterfahrung mit intravesikaler Botoxinjektion : Anwendung bei therapierefraktärer idiopathischer OAB-Symptomatik. Gynäkologie, (3):2-6.

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Imesch, P; Fink, D; Fedier, A (2010). Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertility and Sterility, 94(7):2838-2842.

Peruccini, D; Betschart, C; Fink, D; Scheiner, D (2010). Schlingenoperationen bei Belastungsinkontinenz: Reicht eine einzige Schlinge für alle Indikationen? Leading Opinions. Medizin für die Frau, 3(2):22-26.

Jacob, F; Goldstein, D R; Fink, D; Heinzelmann-Schwarz, V (2009). Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomarkers in Medicine, 3(6):743-756.

Bajka, M; Tuchschmid, S; Streich, M; Fink, D; Székely, G; Harders, M (2009). Evaluation of a new virtual-reality training simulator for hysteroscopy. Surgical Endoscopy, 23(9):2026-2033.

Matzinger, B; Wolf, M; Baños, A; Fink, D; Hornung, R (2009). Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers in Medical Science, 24(4):561-566.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Dedes, K J; Matter-Walstra, K; Schwenkglenks, M; Pestalozzi, B C; Fink, D; Brauchli, P; Szucs, T D (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation. European Journal of Cancer, 45(8):1397-1406.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2009). Anticholinerge Therapie der hyperaktiven Blase. Ars Medici, (3):18-23.

Dedes, K J; Fink, D (2009). Clinical Presentation and Surgical Management of Invasive Lobular Carcinoma of the Breast. Breast Disease, 30:31-37.

Fink, D; Lang, U; Kimmig, R (2009). Einsatz der Laparoskopie in der gynäkologischen Onkologie. Gynäkologisch-Geburtshilfliche Rundschau, 49(3):109-110.

Lang, U; Fink, D; Kimmig, R (2009). Intrauterine Programmierung spezifischer Organsysteme. Gynäkologisch-geburtshilfliche Rundschau, 49(1):1.

Fehr, M K; Fink, D (2009). Karzinosarkome des Uterus, maligne Müller-Mischtumoren des Uterus, Maligne mesodermale Mischtumoren, Maligne gemischte mesenchymale Tumoren (MMMT). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 53-58.

Imesch, P; Dedes, K; Fink, D (2009). Laparoskopische Therapie des Korpuskarzinoms: Datenlage und Evidenz. Gynäkologisch-geburtshilfliche Rundschau, 49(3):111-116.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Fehr, M K; Fink, D (2009). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 33-51.

Fink, D; Fehr, M K (2009). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 133-141.

Fehr, M K; Fink, D (2009). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 59-65.

Gabriel, N; Fink, D (2009). Management des Mammakarzinoms Nebenwirkungen der endokrinen Therapie. Leading Opinions. Medizin für die Frau, 3:26-28.

Imthurn, B; Kimmig, R; Lang, U; Fink, D (2009). Neue Entwicklungen in der Fortpflanzungsmedizin. Gynäkologisch-geburtshilfliche Rundschau, 49(2):53-44.

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Betschart, C; Scheiner, D; Maake, C; Vich, M; Slomianka, L; Fink, D; Perucchini, D (2008). Histomorphological analysis of the urogenital diaphragm in elderly women: a cadaver study. International Urogynecology Journal, 19(11):1477-1481.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Fink, D (2008). Adjuvante Systemtherapie und Tumornachsorge beim Mammakarzinom: State of the Art 2007. In: Redaelli, C. IZS Jahrbuch 2007. Zürich: Interdisziplinäres Zürcher Symposium, 49-61.

Dedes, K J; Gabriel, N; Fink, D (2008). Aktuelle adjuvante endokrine Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):130-137.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2008). Anticholinerge Therapie der hyperaktiven Blase: Wie wird optimiert? Gynäkologie, (5):23-28.

Sinha, C; Köhler, H; Fink, D (2008). Continuous Medical Education. Praxis, 97(25):1321-1328; quiz 1329-1330.

Imesch, P; Fink, D (2008). Das Endometriumkarzinom: Epidemiologie, Präkanzerosen, Diagnostik, Therapie und Nachsorge. Schweizer Zeitschrift für Onkologie, (5):6-10.

Schmidt, A M; Fink, D (2008). Das Ovarialkarzinom: Aktuelle Therapiestrategien im frühen und fortgeschrittenen Stadium. Schweizer Zeitschrift für Onkologie, (5):12-14.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Das Urethralsyndrom: Prävalenz, Differenzialdiagnose,Therapie. Gynäkologie, (2):14-16.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Lang, U; Fink, D; Kimmig, R (2008). Fetale Programmierung = Fetal programming. Gynäkologisch-Geburtshilfliche Rundschau, 48(4):205-206.

Fink, D (2008). Ideal in der Praxis: die gynäkologisch-onkologische Nachsorge. Schweizer Zeitschrift für Onkologie, (5):1.

Betschart, C; Scheiner, D; Fink, D; Perucchini, D (2008). Konservative Therapie von Harninkontinenz, Drangsymptomen und Genitaldeszensus. Journal für Urologie und Urogynäkologie, 15(3):23-30.

Kimmig, R; Fink, D; Lang, U (2008). Körperliche Integrität versus onkologische Sicherheit: Synthese wichtiger Aspekte in der Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(2):55.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Moderne Schlingentechniken bei Belastungsinkontinenz: Technik, Studienresultate, Komplikationen, Differenzialindikation. Gynäkologie, (2):17-22.

Dedes, K J; Beneder, C; Samartzis, N; Muller, M D; Fink, D; Fehr, M K (2008). Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. Journal of Reproductive Medicine, 53(12):947-951.

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Blochlinger-Wegmann, B; Werner, M; Scheiner, D; Fink, D; Perucchini, D (2008). Urethraldivertikel als Ursache chronischer urogenitaler Schmerzen: Ein Fallbericht. Gynäkologisch-Geburtshilfliche Rundschau, 48(1):35-37.

Fink, D; Lang, U; Kimmig, R (2008). Wichtige Fortschritte in der adjuvanten Systemtherapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):111-112.

Fink, Daniel

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Schumpf, Lea F; Theill, Nathan; Scheiner, David A; Fink, Daniel; Riese, Florian; Betschart, Cornelia (2017). Urinary incontinence and its association with functional physical and cognitive health among female nursing home residents in Switzerland. BMC Geriatrics, 17(1):17.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Schraag, Sabrina M; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Schmidt, Ana-Maria (2017). Uterine tumors resembling ovarian sex cord tumors: treatment, recurrence, pregnancy and brief review. Gynecologic Oncology Reports, 19:53-56.

Betschart, Cornelia; Ghisu, Gian-Piero; Fink, Daniel (2016). Normale und abnorme kolposkopische Befunde. Praxis, 105(23):1363-1369.

Scheiner, David; Bracone, Gabriela; Imesch, Patrick; Fink, Daniel; Imthurn, Bruno (2016). Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue. Journal of Ovarian Research, 9(1):59.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Blut im Urin, was nun? Abklärung der nicht-sichtbaren Hämaturie bei der Frau. Praxis, 105(19):1133-1141.

Schmidt, Ana-Maria; Imesch, Patrick; Fink, Daniel; Egger, Herwig (2016). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients. International Journal of Gynecological Cancer, 26(4):716-721.

Imesch, Patrick; Fink, Daniel (2016). Endometriosis Update 2016. Praxis, 105(5):253-257.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Botox für die Blase. Leading Opinions - Gynäkologie & Geburtshilfe:25-29.

Baege, Astrid; Ghisu, Gian-Piero; Betschart, Cornelia; Fink, Daniel (2016). Die HPV-Impfung und -Typisierung in der Primär- und Sekundärprävention: Stellenwert in der Praxis. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):20-24.

Fink, Daniel (2016). Editorial: Die Dysplasie-Sprechstunde. Gynäkologie, 4:1.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Erythrozyten im Harn. Internistische Praxis:673-680.

Dedes, Konstantin J; Fink, Daniel (2016). Mammakarzinom in der Schwangerschaft. info@gynäkologie, 6:18-21.

Perucchini, Daniele; Scheiner, David A; Fink, Daniel; Betschart, Cornelia (2016). Management der Mischinkontinenz. Schritt für Schritt zum Erfolg – Diagnostik, Therapie, Beratung. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:15-20.

Ghisu, Gian-Piero; Fink, Daniel (2016). Medikamentös oder chirurgisch? State of the Art der Abortbehandlung in der Frühschwangerschaft. info@gynäkologie, 2:12-14.

Imesch, Patrick; Fink, Daniel (2016). Nachsorge in der gynäkologischen Onkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 5:6-9.

Pestalozzi, Bernhard; Leo, Cornelia; Fink, Daniel (2016). Neoplasien der weiblichen Geschlechtsorgane: Mammakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 373-385.

Betschart, Cornelia; Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2016). Normale und abnormale kolposkopische Befunde: Klassifikation und Bedeutung: Welche Befunde sind „gefährlich“? Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):6-13.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Rezidivierende Harnwegsinfekte : Komplikationen, Therapieoptionen, Prävention. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:6-14.

Ghisu, Gian-Piero; Baege, Astrid; Betschart, Cornelia; Fink, Daniel (2016). Therapie bei dysplastischen Veränderungen in der Gynäkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 4:14-19.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2016). Urininkontinenz und Sexualität. Hausarzt Praxis:2-4.

Ghisu, Gian-Piero; Fink, Daniel (2016). Verlauf der HPV-Infektion und Einteilung kolposkopischer Befunde. Gynaekologische Praxis, 41(2):187-199.

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Vaso, Martin; Betschart, Cornelia; Egger, Herwig; Fink, Daniel; Schmidt, Ana-Maria (2015). Surgical technique of a recurrent post-radiation vesicovaginal fistula with a small intestine graft. Archives of Gynecology and Obstetrics, 292(3):485-488.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2015). Interstitial cystitis/bladder pain syndrome (IC/BPS). Praxis, 104(17):909-918.

Ghisu, Gian-Piero; Fink, Daniel (2015). Burning vulva: significance of surgery in inflammatory and precancerous vulvar pathologies. Praxis, 104(13):689-693.

Birindelli, Esther; Fink, Daniel (2015). Abnormal Early Pregnancy: What Matters for Practice. Praxis, 104(12):617-621.

Hempen, Aline; Samartzis, Eleftherios P; Kamarachev, Jivko; Fink, Daniel; Dedes, Konstantin J (2015). Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report. BMC Cancer, 15(507):online.

Imesch, Patrick; Fink, Daniel (2015). Aktuelle Diagnostik und operative Therapie der Endometriose in der Praxis. info@gynäkologie, 2015(3):18-20.

Sikora, Michal; Scheiner, David; Betschart, Cornelia; Perucchini, Daniele; Mateos, José María; di Natale, Anthony; Fink, Daniel; Maake, Caroline (2015). Label-free, three-dimensional multiphoton microscopy of the connective tissue in the anterior vaginal wall. International Urogynecology Journal and Pelvic Floor Dysfunction, 26(5):685-691.

Ihnenfeld Arciénega, Isabel; Imesch, Patrick; Fink, Daniel; Dedes, Konstantin J (2015). Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature. Targeted oncology, 10(2):297-301.

Noske, Aurelia; Henricksen, Leigh A; LaFleur, Bonnie; Zimmermann, Anne-Katrin; Tubbs, Alisa; Singh, Shalini; Storz, Martina; Fink, Daniel; Moch, Holger (2014). Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Experimental and Molecular Pathology, 98(1):47-54.

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Samartzis, Eleftherios P; Gutsche, Katrin; Dedes, Konstantin J; Fink, Daniel; Stucki, Manuel; Imesch, Patrick (2014). Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. OncoTarget, 5(14):5295-5303.

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Strutas, Deivis; Betschart, Cornelia; Fink, Daniel (2014). Das Vestibulitissyndrom. Gynäkologie, 4:25-19.

Corpet, Armelle; Olbrich, Teresa; Gwerder, Myriam; Fink, Daniel; Stucki, Manuel (2014). Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle, 13(2):0-18.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Erythrozyten im Harn. Wie ist das weitere Vorgehen? Gynaekologische Praxis, 38(2):271-279.

Baege, Astrid; Ghisu, Gian-Piero; Fink, Daniel (2014). Follow-up nach Therapie einer CIN, einer VIN und einer VAIN. Gynäkologie, 4:20-24.

Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2014). HPV-assoziierte Genitalerkrankungen. Gynäkologie, 4:14-19.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 57-62.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 37-56.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heildelberg: Springer Verlag, 65-70.

Lohri, Corinne; Hutzli Schaltegger, Claudia S; van den Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Research, 34:4693-4700.

Fink, Daniel (2014). News from the San Antonio Breast Cancer Symposium 2013. Breast Care, 9(1):66-68.

Fink, Daniel (2014). Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag.

Samartzis, Eleftherios P; Noske, Aurelia; Meisel, Alexander; Varga, Zsuzsanna; Fink, Daniel; Imesch, Patrick (2014). The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer. PLoS ONE, 9(1):e83296.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Vom Fettgift zum modernen Therapeutikum – Botulinumneurotoxine. info@gynäkologie, 5:20-22.

Betschart, Cornelia; Strutas, Deivis; Fink, Daniel (2014). Vulvadermatosen. Gynäkologie, 4:6-12.

Samartzis, Eleftherios P; Noske, Aurelia; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2013). ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. International Journal of Molecular Sciences, 14(9):18824-18849.

Ghisu, Gian-Piero; Fink, Daniel (2013). Frühaborte und Abruptiones. Operative und medikamentöse Therapie. Gynäkologie, (1):9-13.

Imesch, Patrick; Samartzis, Eleftherios P; Dedes, Konstantin J; Fink, Daniel; Fedier, André (2013). Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells. Fertility and Sterility, 100(3):770-776.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Botox in der Schwangerschaft und der Stillzeit. Hebamme.ch = Sage-femme.ch = Levatrice.ch = Spendrera.ch, (6):14-16.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Deszensuschirurgie. Neue und bewährte Techniken. Gynäkologie, (5):6-11.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Die Belastungsinkontinenz. Diagnostik und Therapie. Gynäkologie, (5):12-17.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Die Bildgebung des Beckenbodens. Ultraschall und MRI. Gynäkologie, (5):23-26.

Perucchini, Daniele; Betschart, Cornelia; Scheiner, David; Fink, Daniel (2013). Die überaktive Blase. Differenzialdiagnostik und therapeutisches Management. Gynäkologie, (5):18-22.

Imesch, Patrick; Fink, Daniel (2013). Das Endometriumkarzinom: Diagnostik und Therapie. Schweizer Zeitschrift für Onkologie, (4):2-6.

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Imesch, Patrick; Scheiner, David; Szabo, Emese; Fink, Daniel; Fedier, André (2013). Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells. Experimental and Therapeutic Medicine, 6(3):786-790.

Imesch, Patrick; Scheiner, David; Xie, Min; Fink, Daniel; Macas, Erwin; Dubey, Raghvendra; Imthurn, Bruno (2013). Developmental potential of human oocytes matured in vitro followed by vitrification and activation. Journal of Ovarian Research, 6:30.

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Betschart, Cornelia; Mol, Suzanne E; Lütolf-Keller, Béatrice; Fink, Daniel; Perucchini, Daniele; Scheiner, David (2013). Pelvic floor muscle training for urinary incontinence: a comparison of outcomes in premenopausal versus postmenopausal women. Female Pelvic Medicine and Reconstructive Surgery, 19(4):219-224.

Betschart, Cornelia; von Mandach, Ursula; Seifert, Burkhardt; Scheiner, David; Perucchini, Daniele; Fink, Daniel; Geissbühler, Verena (2013). Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, 20(3-4):351-358.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Samartzis, Eleftherios P; Noske, Aurelia; Samartzis, Nicolas; Fink, Daniel; Imesch, Patrick (2013). The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in Endometriosis. Reproductive Sciences, 20(12):1416-1422.

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Samartzis, Nicolas; Samartzis, Eleftherios P; Noske, Aurelia; Fedier, Andre; Dedes, Konstantin J; Caduff, Rosmarie; Fink, Daniel; Imesch, Patrick (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology, 10:30.

Scheiner, D; Perucchini, D; Fink, Daniel; Betschart, C (2012). Gynäkologie: Fälle aus der Harninkontinenz-Sprechstunde. Praxis, 101(9):585-592.

Schmidt, A-M; Imesch, P; Fink, Daniel; Egger, H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecologic oncology, 125(3):604-609.

Samartzis, Eleftherios P; Samartzis, Nicolas; Noske, Aurelia; Fedier, André; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2012). Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? Modern Pathology, 25(6):885-892.

Church, D N; Koppensteiner, R; Yap, T; Fink, Daniel; Dedes, K J (2012). P13K-AKT-mTOR inhibitors for the systematic treatment of endometrial cancer. Expert Review of Obstetrics & Gynecology, 7(5):421-430.

Dedes, K J; Fink, Daniel; Steiner, R A (2012). Principes de la chimiothérapie. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 50-54.

Fink, Daniel; Leo, C (2012). Synopsis des principales études concernant le traitement du cancer du sein au stade métastatique. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 72-82.

Schneider, Priska; von Orelli, Stephanie; Roos, Malgorzata; Leo, Cornelia; Fink, Daniel; Wyss, Pius (2012). The value of endocervical curettage after conization for cervical intraepithelial neoplasia. Annals of Diagnostic Pathology, 16(4):245-249.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Fehr, Mathias K; Hornung, René; Degen Iseli, Andrea Franziska; Schwarz, Viola A; Fink, Daniel; Haller, Urs; Wyss, Pius (2002). Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers in surgery and medicine, 30(4):273-279.

Fink, Daniel A

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Fischer, H

Bajka, M; Weiss, S; Kunz, J; Fischer, H; Székely, G; Niederer, P (2009). Pressure-dependent hydrometra dimensions in hysteroscopy. Surgical Endoscopy, 23(9):2102-2109.

Fischer, S

Fischer, S. Diagnostische und Therapeutische Optionen beim Management von Patientinnen mit Zervixkarzinom. 2009, University of Zurich, Faculty of Medicine.

Folkers, G

Kut, E; Candia, V; von Overbeck, J; Pok, J; Fink, D; Folkers, G (2011). Pleasure-related analgesia activates opioid-insensitive circuits. Journal of Neuroscience, 31(11):4148-53.

Forbes, J F

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Ford, Caroline

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Ford, Caroline E

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Forster, M D

Forster, M D; Dedes, K J; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C J; Weigelt, B; Kaye, S B; Rhoda Molife, L (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):302-306.

Frankum, J

Wilkerson, P M; Dedes, K J; Wetterskog, D; Mackay, A; Lambros, M B; Mansour, M; Frankum, J; Lord, C J; Natrajan, R; Ashworth, A; Reis-Filho, J S (2011). Functional characterization of EMSY gene amplification in human cancers. Journal of Pathology, 225(1):29-42.

Frankum, J R

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Frei, C

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Frentzas, S

Forster, M D; Dedes, K J; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C J; Weigelt, B; Kaye, S B; Rhoda Molife, L (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):302-306.

Frew, Ian J

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Fritzsche, F R

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Fuchs, B

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Fuchs, Thomas

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Fuchs, Thomas J

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Fuenfschilling, Maya

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Furlato, M

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Furlato, M A

Furlato, M A. Erzeugung von Histondeazetylase-Hemmer-resistenten Tumorzellen durch mehrfache Behandlung mit ansteigenden Konzentrationen von Trichostatin A. 2009, University of Zurich, Faculty of Medicine.

Fürer, K

Fürer, K; et al; von Mandach, U (2015). Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum - a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine, 22(1):158-164.

Gabrecht, Tanja

Degen Iseli, Andrea Franziska; Gabrecht, Tanja; Mosimann, Laurent; Fehr, Mathias K; Hornung, René; Schwarz, Viola A; Tadir, Yona; Steiner, Rolf A; Wagnières, Georges; Wyss, Pius (2004). Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers in surgery and medicine, 34(1):1-4.

Gabriel, N

Kohl Schwartz, A S; Leo, C; Rufibach, Kaspar; Varga, Z; Fink, D; Gabriel, N (2013). Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure? European Journal of Surgical Oncology, 39(3):266-272.

Imesch, P; Fink, D; Gabriel, N (2012). Was bringt ein Screening beim Ovarial- und Korpus-Ca? Leading Opinions Medizin für die Frau, (3):28-30.

Gabriel, N; Fink, D (2011). Lifestyleänderungen nach Mammakarzinom. Empfohlene Massnahmen und Fragen in der Beratung. Gynäkologie, (4):6-9.

Gabriel, N; Fink, D (2010). 32nd San Antonio Breast Cancer Symposium: Highlights aus San Antonio. Leading Opinions. Medizin für die Frau, 3(2):39-40.

Gabriel, N; Fink, D (2009). Management des Mammakarzinoms Nebenwirkungen der endokrinen Therapie. Leading Opinions. Medizin für die Frau, 3:26-28.

Dedes, K J; Gabriel, N; Fink, D (2008). Aktuelle adjuvante endokrine Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):130-137.

Gabriel, N (2008). Nebenwirkungen der endokrinen Therapie beim Mammakarzinom: Erkennen, Vorsorgen und Behandeln. Schweizer Zeitschrift für Onkologie, (5):16-20.

Gauthier, Arnaud

Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; Töpfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.

Gautschi, Oliver

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Geissbühler, V

Kociszewski, J; Rautenberg, O; Perucchini, D; Eberhard, J; Geissbühler, V; Hilgers, R; Viereck, V (2008). Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourology and Urodynamics, 27(6):485-490.

Geissbühler, Verena

Betschart, Cornelia; von Mandach, Ursula; Seifert, Burkhardt; Scheiner, David; Perucchini, Daniele; Fink, Daniel; Geissbühler, Verena (2013). Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, 20(3-4):351-358.

Gelber, R D

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Regan, M M; Price, K N; Giobbie-Hurder, A; Thürlimann, B; Gelber, R D (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Research, 13(3):209.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Giobbie-Hurder, A; Price, K N; Gelber, R D; et al; Varga, Z; Moch, H; Caduff, R (2009). Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical Trials, 6(3):272-287.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Georgiev, Strahil

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Gerhard, M

Toller, I M; Neelsen, K J; Steger, M; Hartung, M L; Hottiger, M O; Stucki, M; Kalali, B; Gerhard, M; Sartori, A A; Lopes, M; Müller, A (2011). Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(36):14944-14949.

Geyer, F C

Dedes, K J; Natrajan, R; Lambros, M B; Geyer, F C; Lopez-Garcia, M A; Savage, K; Jones, R L; Reis-Filho, J S (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. European Journal of Cancer, 47(1):138-150.

Dedes, K J; Lopez-Garcia, M A; Geyer, F C; Lambros, M B K; Savage, K; Vatcheva, R; Wilkerson, P; Wetterskog, D; Lacroix-Triki, M; Natrajan, R; Reis-Filho, J S (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment, 124(3):653-666.

Lambros, M B; Natrajan, R; Geyer, F C; Lopez-Garcia, M A; Dedes, K J; Savage, K; Lacroix-Triki, M; Jones, R L; Lord, C J; Linardopoulos, S; Ashworth, A; Reis-Filho, J S (2010). PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Modern Pathology, 23(10):1334-1345.

Dedes, K J; Wetterskog, D; Mendes-Pereira, A M; Natrajan, R; Lambros, M B; Geyer, F C; Vatcheva, R; Savage, K; Mackay, A; Lord, C J; Ashworth, A; Reis-Filho, J S (2010). PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Science Translational Medicine, 2(53):53ra75.

Ghisu, Gian-Piero

Betschart, Cornelia; Ghisu, Gian-Piero; Fink, Daniel (2016). Normale und abnorme kolposkopische Befunde. Praxis, 105(23):1363-1369.

Baege, Astrid; Ghisu, Gian-Piero; Betschart, Cornelia; Fink, Daniel (2016). Die HPV-Impfung und -Typisierung in der Primär- und Sekundärprävention: Stellenwert in der Praxis. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):20-24.

Ghisu, Gian-Piero; Fink, Daniel (2016). Medikamentös oder chirurgisch? State of the Art der Abortbehandlung in der Frühschwangerschaft. info@gynäkologie, 2:12-14.

Betschart, Cornelia; Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2016). Normale und abnormale kolposkopische Befunde: Klassifikation und Bedeutung: Welche Befunde sind „gefährlich“? Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):6-13.

Ghisu, Gian-Piero; Baege, Astrid; Betschart, Cornelia; Fink, Daniel (2016). Therapie bei dysplastischen Veränderungen in der Gynäkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 4:14-19.

Ghisu, Gian-Piero; Fink, Daniel (2016). Verlauf der HPV-Infektion und Einteilung kolposkopischer Befunde. Gynaekologische Praxis, 41(2):187-199.

Ghisu, Gian-Piero; Fink, Daniel (2015). Burning vulva: significance of surgery in inflammatory and precancerous vulvar pathologies. Praxis, 104(13):689-693.

Baege, Astrid; Ghisu, Gian-Piero; Fink, Daniel (2014). Follow-up nach Therapie einer CIN, einer VIN und einer VAIN. Gynäkologie, 4:20-24.

Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2014). HPV-assoziierte Genitalerkrankungen. Gynäkologie, 4:14-19.

Ghisu, Gian-Piero; Fink, Daniel (2013). Frühaborte und Abruptiones. Operative und medikamentöse Therapie. Gynäkologie, (1):9-13.

Ghoneimi, Alaa El

Panel, Pierre; Bajka, Michael; Le Tohic, Arnaud; Ghoneimi, Alaa El; Chis, Carmen; Cotin, Stéphane (2012). Hysteroscopic placement of tubal sterilization implants: virtual reality simulator training. Surgical Endoscopy, 26(7):1986-1996.

Gianni, L

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Gillespie, D G

Barchiesi, F; Lucchinetti, E; Zaugg, M; Ogunshola, O O; Wright, M; Meyer, Markus; Rosselli, M; Schaufelberger, S; Gillespie, D G; Jackson, E K; Dubey, R K (2010). Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension, 56(5):964-972.

Giobbie-Hurder, A

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Regan, M M; Price, K N; Giobbie-Hurder, A; Thürlimann, B; Gelber, R D (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Research, 13(3):209.

Giobbie-Hurder, A; Price, K N; Gelber, R D; et al; Varga, Z; Moch, H; Caduff, R (2009). Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical Trials, 6(3):272-287.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Viale, G; Giobbie-Hurder, A; Regan, M M; Stahel, R A (2008). Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Journal of Clinical Oncology, 26(34):5569-5575.

Gloss, B S

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Godstaub, E

Godstaub, E. Diagnostik von Brusterkrankungen: Feinnadelpunktion und Stanzbiopsie. 2009, University of Zurich, Faculty of Medicine.

Goehrens, A

Imesch, P; Goehrens, A; Fink, D; Fedier, A (2011). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine)in vitro. Oncology Letters, 3(2):441-444.

Goerens, Anouk

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Goike, H

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Goldhirsch, A

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Goldinger, Simone M

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Goldstein, D

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Goldstein, D R

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Jacob, F; Goldstein, D R; Fink, D; Heinzelmann-Schwarz, V (2009). Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomarkers in Medicine, 3(6):743-756.

Goldstein, Darlene R

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Gourley, C

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Graf, Dimitri

Graf, Dimitri. Interaktive Konzepte im E-Learning der Frauenheilkunde und Neonatologie. 2014, University of Zurich, Faculty of Medicine.

Graf, N

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Graf, Nina

Graf, Nina. Frequency and risk factors of lower limb lymphedema following lymphadenecomy in patients with gynecological malignancies. 2013, University of Zurich, Faculty of Medicine.

Gratacos, Eduard

Mazza, Edoardo; Parra-Saavedra, Miguel; Bajka, Michael; Gratacos, Eduard; Nicolaides, Kypros; Deprest, Jan (2014). In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy. Prenatal Diagnosis, 34(1):33-41.

Grau, P

Mazza, E; Grau, P; Hollenstein, M; Bajka, M (2008). Constitutive modeling of human liver based on in vivo measurements. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Berlin / Heidelberg: Springer, 726-733.

Grimm, Christian

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Gropp, M

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Grøfte, Merete

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Guaita, Alessandra

Guaita, Alessandra. Fallkontrollstudie zur Steroidrezeptor-Expression in der vorderen Vaginalwand bei Frauen mit Zystozele und gesunden Kontrollen mittels Lasercapture Microdissection, Präamplifikation und quantitativer PCR. 2016, University of Zurich, Faculty of Medicine.

Gubler, Andrea

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Guertler, Rea

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Guller, U

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Gurard-Levin, Zachary A

Abascal, Federico; Corpet, Armelle; Gurard-Levin, Zachary A; Juan, David; Ochsenbein, Françoise; Rico, Daniel; Valencia, Alfonso; Almouzni, Geneviève (2013). Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution, 30(8):1853-1866.

Gusterson, B A

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Gutsche, Katrin

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Samartzis, Eleftherios P; Gutsche, Katrin; Dedes, Konstantin J; Fink, Daniel; Stucki, Manuel; Imesch, Patrick (2014). Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. OncoTarget, 5(14):5295-5303.

Gwerder, Myriam

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Corpet, Armelle; Olbrich, Teresa; Gwerder, Myriam; Fink, Daniel; Stucki, Manuel (2014). Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle, 13(2):0-18.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Gygax, N

Gygax, N. Laparoskopische Sakropexie – Machbarkeit, perioperatives Outcome und Kurzzeitkomplikationen von 99 an der Frauenklinik Kantonsspital Aarau operierten Patientinnen. 2009, University of Zurich, Faculty of Medicine.

Günthert, A R

Achtari, C; Fink, D; Günthert, A R; Huober, J; Pestalozzi, B; Petignat, P; von Moos, R; Sessa, C (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer – some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 35(1):35-38.

Hacker, N

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Hacker, N F

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Hacker, Neville

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Hacker, Neville F

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Haddad, Jorge Milhem

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Hafez, Ahmed A

Nygaard, Christiana Campani; Betschart, Cornelia; Hafez, Ahmed A; Lewis, Erica; Chasiotis, Ilias; Doumouchtsis, Stergios K (2013). Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction, 24(12):2071-2076.

Hahmann, M

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Hahnloser, D

Müller, M K; Dedes, K J; Dindo, D; Steiner, S; Hahnloser, D; Clavien, P A (2009). Impact of clinical pathways in surgery. Langenbeck's Archives of Surgery, 394(1):31-39.

Haire, Lesley F

Jungmichel, Stephanie; Clapperton, Julie A; Lloyd, Janette; Hari, Flurina J; Spycher, Christoph; Pavic, Lucijana; Li, Jiejin; Haire, Lesley F; Bonalli, Mario; Larsen, Dorthe H; Lukas, Claudia; Lukas, Jiri; MacMillan, Derek; Nielsen, Michael L; Stucki, Manuel; Smerdon, Stephen J (2012). The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator. Nucleic Acids Research, 40(9):3913-3928.

Haldemann Heusler, R

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Hall, Timothy J

Myers, Kristin M; Feltovich, Helen; Mazza, Edoardo; Vink, Joy; Bajka, Michael; Wapner, Ronald J; Hall, Timothy J; House, Michael (2015). The mechanical role of the cervix in pregnancy. Journal of Biomechanics, 48(9):1511-1523.

Hallensleben, E

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Haller, Urs

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs; Fehr, Mathias (2003). Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study. Lasers in surgery and medicine, 33(3):209-212.

Wyss, Pius; Caduff, Rosmarie; Tadir, Yona; Degen Iseli, Andrea Franziska; Wagnières, Georges; Schwarz, Viola; Haller, Urs; Fehr, Mathias (2003). Photodynamic endometrial ablation: morphological study. Lasers in surgery and medicine, 32(4):305-309.

Fehr, Mathias K; Hornung, René; Degen Iseli, Andrea Franziska; Schwarz, Viola A; Fink, Daniel; Haller, Urs; Wyss, Pius (2002). Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers in surgery and medicine, 30(4):273-279.

Hampl, Monika

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Hany, T F

Burger, I A; Scheiner, D A; Crook, D W; Treyer, V; Hany, T F; von Schulthess, G K (2011). FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position. European Journal of Nuclear Medicine and Molecular Imaging, 38(1):90-96.

Hanzal, E

Hanzal, E; Scheiner, D (2010). Therapie der Belastungsinkontinenz. In: Tunn, R; Hanzal, E; Perucchini, D. Urogynäkologie in Praxis und Klinik (2. Aufl.). Berlin, DE: de Gruyter, 161-184.

Harders, M

Bajka, M; Tuchschmid, S; Fink, D; Székely, G; Harders, M (2010). Establishing construct validity of a virtual-reality training simulator for hysteroscopy via a multimetric scoring system. Surgical Endoscopy, 24(1):79-88.

Bajka, M; Tuchschmid, S; Streich, M; Fink, D; Székely, G; Harders, M (2009). Evaluation of a new virtual-reality training simulator for hysteroscopy. Surgical Endoscopy, 23(9):2026-2033.

Niederer, P; Weiss, S; Caduff, R; Bajka, M; Szekély, G; Harders, M (2009). Uterus models for use in virtual reality hysteroscopy simulators. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144, S:S90-S95.

Tuchschmid, S; Bajka, M; Szczerba, D; Lloyd, B A; Székely, G; Harders, M (2008). Modeling intravasation of liquid distension media in surgical simulators. Medical Image Analysis, 12(5):567-576.

Hari, Flurina

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Hari, Flurina J

Jungmichel, Stephanie; Clapperton, Julie A; Lloyd, Janette; Hari, Flurina J; Spycher, Christoph; Pavic, Lucijana; Li, Jiejin; Haire, Lesley F; Bonalli, Mario; Larsen, Dorthe H; Lukas, Claudia; Lukas, Jiri; MacMillan, Derek; Nielsen, Michael L; Stucki, Manuel; Smerdon, Stephen J (2012). The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator. Nucleic Acids Research, 40(9):3913-3928.

Harlozinska, A

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Harter, P

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Hartung, M L

Toller, I M; Neelsen, K J; Steger, M; Hartung, M L; Hottiger, M O; Stucki, M; Kalali, B; Gerhard, M; Sartori, A A; Lopes, M; Müller, A (2011). Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(36):14944-14949.

Hasenburg, A

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Hauptmann, S

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Hauser, Nik

Hauser, Nik. Development and Clinical Evaluation of New Approaches in Breast Cancer Diagnosis: Differential Phase Contrast Mammography. 2013, University of Zurich, Faculty of Medicine.

Hawle, H

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Heinzelmann-Schwarz, V

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Heinzelmann-Schwarz, V (2011). Das epitheliale Ovarialkarzinom – ein Paradigmenwandel. Therapeutische Umschau, 68(10):565-572.

Pochechueva, T; Chinarev, A; Spengler, M; Korchagina, E; Heinzelmann-Schwarz, V; Bovin, N; Rieben, R (2011). Multiplex suspension array for human anti-carbohydrate antibody profiling. The Analyst, 136(3):560-569.

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Jacob, F; Goldstein, D R; Fink, D; Heinzelmann-Schwarz, V (2009). Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomarkers in Medicine, 3(6):743-756.

Heinzelmann-Schwarz, V A

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Heinzelmann-Schwarz, Viola

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Heinzelmann-Schwarz, Viola A

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Heinzl, Siegfried

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Helbling, M

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Hempen, Aline

Hempen, Aline; Samartzis, Eleftherios P; Kamarachev, Jivko; Fink, Daniel; Dedes, Konstantin J (2015). Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report. BMC Cancer, 15(507):online.

Henderson, M J

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Henricksen, Leigh A

Noske, Aurelia; Henricksen, Leigh A; LaFleur, Bonnie; Zimmermann, Anne-Katrin; Tubbs, Alisa; Singh, Shalini; Storz, Martina; Fink, Daniel; Moch, Holger (2014). Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Experimental and Molecular Pathology, 98(1):47-54.

Henry, Claire

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Henshall, S M

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Hentschel, B

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Horn, L-C; Hentschel, B; Meinel, A; Alexander, H; Leo, C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Annals of Diagnostic Pathology, 13(6):373-377.

Henzi, N

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Hess, E

Betschart, C; Scheiner, D; Hess, E; Seifert, Burkhardt; Fink, D; Perucchini, D (2011). Patient satisfaction after retropubic and transobturator slings: first assessment using the Incontinence Outcome Questionnaire (IOQ). International Urogynecology Journal, 22(7):805-812.

Hess, T

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Hess-Arnold, E

Hess-Arnold, E. Patientinnenzufriedenheit nach retropubischer und transobturatorischer Schlingenoperation : Langzeitergebnisse, erhoben mit dem Incontinence Outcome Questionnaire (IOQ). 2011, University of Zurich, Faculty of Medicine.

Heuer, H

Schnabel, J; Heuer, H; Dedes, K; Fink, D (2014). Hochrisikokonstellation für Brustkrebs. Schweizer Zeitschrift für Onkologie, 3:28-32.

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Hildebrandt, G

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Hilgers, R

Kociszewski, J; Rautenberg, O; Perucchini, D; Eberhard, J; Geissbühler, V; Hilgers, R; Viereck, V (2008). Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourology and Urodynamics, 27(6):485-490.

Hilpert, F

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Hirsch, S

Hirsch, S; Szczerba, D; Lloyd, B; Bajka, M; Kuster, N; Székely, G (2011). Mechano-chemical simulation of solid tumor dynamics for therapy outcome predictions. International Journal for Multiscale Computational Engineering, 9(2):231-241.

Hohl, M

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Hohl, M K

Mueller, M; Eberhard, M; De Geyter, C; Häberlin, F; Hohl, M K; Imesch, P; Polli, C; Possover, M; Schiessl, K; Wenger, J M; Wunder, D (2012). Diagnostik und Therapie der Endometriose. Frauenheilkunde Aktuell, 21(2):28-34.

Hollenstein, M

Hollenstein, M; Bajka, M; Röhrnbauer, B; Badir, S; Mazza, E (2012). Measuring the in vivo behavior of soft tissue and organs using the aspiration device. In: Payan, Y. Soft Tissue Biomechanical Modeling for Computer Assisted Surgery. Heidelberg: Springer, 201-228.

Mazza, E; Grau, P; Hollenstein, M; Bajka, M (2008). Constitutive modeling of human liver based on in vivo measurements. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Berlin / Heidelberg: Springer, 726-733.

Holzapfel, G A

Bauer, M; Mazza, E; Jabareen, M; Sultan, L; Bajka, M; Lang, U; Zimmermann, R; Holzapfel, G A (2009). Assessment of the in vivo biomechanical properties of the human uterine cervix in pregnancy using the aspiration test: a feasibility study. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144(Suppl ):S77-S81.

Holzmann, David

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Honegger, C

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Honegger, Christoph

Charpidou, Theodosia; Lang, Franziska; Langenegger, Thomas; Dedes, Konstantin J; Honegger, Christoph (2013). Bilateral transient osteoporosis of the knee during pregnancy. Archives of Gynecology and Obstetrics, 287(6):1259-1261.

Horn, L C

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Horn, L-C

Horn, L-C; Hentschel, B; Meinel, A; Alexander, H; Leo, C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Annals of Diagnostic Pathology, 13(6):373-377.

Hornung, Daniela

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Hornung, R

Imesch, P; Hornung, R; Fink, D; Fedier, A (2011). Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecologic and Obstetric Investigation, 72(1):43-49.

Matzinger, B; Wolf, M; Baños, A; Fink, D; Hornung, R (2009). Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers in Medical Science, 24(4):561-566.

Stahel, M C; Wolf, M; Baños, A; Hornung, R (2009). Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles. Lasers in Medical Science, 24(6):901-907.

Hornung, Rene

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs;